Ubiquitous Monitoring for all Levels of Care
Current Challenges in Long Term Care and Outpatient Services
Outpatient facilities such as Skilled Nursing Facilities are in dire need of a technology that can enable ubiquitous and continuous monitoring for medically complex residents.
Hospital readmissions reduce Medicare Reimbursement, as the facility loses out on potential revenue from Medicare whilst the patient is in their facility.
AEs utilize additional resources days or weeks before a patient expires. Not knowing when a patient might decline puts significant strain on the institution if resources are tight.
Poor Care Outcomes
Adverse Events produce customer dissatisfaction & poor patient outcomes.
Nurse to patient ratios are close to 1:20 or 1:30, making it extremely difficult to acknowledge biomarkers.
Physicians are off site most of the time and are called in, so there is no way for the physician to know of a problem unless the facility notifies the physician as its happening
Poor Data Management
Vitals are taken once a day or once every few days, so it is very difficult to acknowledge Adverse Event biomarkers.
“I have no way of knowing how my patients are when I leave for the night, and I can’t tell you how many times I’ve come back in the morning only to learn that three or four of my patients passed away and I didn’t know” - Chief Physician at a SNF in Ohio
The data practitioners need, when they need it.
Wearable vital signs monitor that can aggregate multiple important metrics every minute and present information on multiple user interfaces for quick insight into the patient’s physiology.
SPO2 / Pulse Oxygen
Heart Rate Variability
By remotely viewing data with the Lumori App, nurses and physicians can see trends over time, chart valuable data points (e.g. weight), and supplement their knowledge with information about a patient’s current physiology .
at your Facility!
This device is for Investigational Use Only. The performance characteristics of this product have not been established. All performance claims listed are project goals only. This device is not yet available for use in the US and is pending submission and clearance by the United States Food and Drug Administration.